Composition for combating bees nosema "noteson" |
|
IPC classes for russian patent Composition for combating bees nosema "noteson" (RU 2081572):
 The way to fight ascosphaerosis bees / 2075293
The invention relates to methods of combating ascosphaerosis bees and can be used on apiaries
 The way to combat varroa bee / 2058731
The invention relates to veterinary medicine, namely to search for new means of protecting bees from parasites, in particular from ticks, varroa jacobsoni
A method of treating bees with fungal diseases / 2052246
The invention relates to beekeeping and can be used for the treatment of fungal diseases of bees, such as Ashteroth
The way zykova, k. struggle with tick-borne diseases of bees / 2048765
The invention relates to beekeeping
 A device for handling bees heated vapors drug / 2048090
The invention relates to beekeeping, namely, devices for handling bees from varroa
 A method of obtaining a polymer plate / 2045176
The invention relates to agriculture, in particular to beekeeping, and can be used for the treatment of bee colonies infected ticks, varroa
Preparation for treating ascospherosis in bees / 2249349
The suggested preparation to treat ascospherosis in bees contains, weight%: nystatin 26-32, thymol 5-9, atox 54-60, furacillin 5-9. The present innovation enables to broaden the number of preparations of high curative action.
 Method for thermal treatment of bees / 2258359
Method involves heating air in thermal chamber by means of heater equipped with thermal regulator and indicator; creating air flow by means of fan; providing treatment directly in bee hive after closing of entrances; putting onto bee hive support with window closed by net for mounting of thermal chamber. Warm air flow is created by fan and supplied into bee hive through window closed by net. Electric iron is used as heater.
 Apparatus for producing of disinfecting aerosol for controlling of bee acariasis and other diseases / 2258360
Apparatus has glowing member and unit formed as plate of flexible material folded into three layers and equipped with perforation in side surface of each layer. In order to prevent folded plate from complete unwinding, glowing member is used to provide development of additional friction forces along axis of plate, said forces being oriented in direction opposite to direction of outer forces tending to displace glowing member.
Composition and method for treatment of brood infected with bee foul brood / 2266000
Composition is adapted for treatment or prophylaxis of American, European foul brood and flakiness and consists of weakened or avirulent bacteria and carrier. Method for treatment or prophylaxis of said diseases involves introducing said composition into beehive. Also, inoculate comprising weakened or avirulent microorganisms and used as active substance for treatment of bee diseases is disclosed. Method allows utilization of antibiotics to be avoided.
Method for disinfection of rooms for storage of apiary equipment and beehives and composition for effectuating the same / 2279214
Method involves treating storage rooms and beehives with sulfur dioxide, with disinfection procedure being conducted so as to provide sulfur dioxide concentration from 120 to 180 g/m3 within 24-40 hours and recirculation ventilation being provided in room under treatment process for 15-20 min each half an hour at flow rate of 1-3 m/s; providing second disinfection procedure with periodicity of 7-10 days after first disinfection procedure and third disinfection procedure 15-20 days after second disinfection procedure. Disinfection composition for treating rooms for storage of apiary equipment and beehives comprises sulfur, gypsum and cement used in 1:1 ratio, and additionally comprises charcoal, said components being used in the following ratio, wt%: sulfur 60-89; gypsum and cement 10-39; charcoal 1-3.
Composition for prophylaxis and treatment of honey bees from parasitic mites / 2282986
Claimed composition contains (mass %): formic acid 76-91; and gel-forming polymer (e.g. polyacryl and potassium polyacrylate) 4-10; and additionally it contains lactic acid 1-14 and balance: essence oil.
 Ecologically clean safe light miniplate for bee keeper / 2285395
Light miniplate for bee keeper has light source with metal reflector, quartz glass, voltage source, and operating mode change over device. Light source is made in the form of halogen lamp, and metal reflector is formed concave and of mirror type. Halogen lamp is connected to 12-volt voltage source for providing irradiation through quartz glass in infrared and ultraviolet spectra.
Composition for combating of honey bee parasitic acarines / 2291613
Claimed composition contains (mass %): formic acid 50-89; menthol 1-10; stabilizer -.01-2; thickener 1-20; and balance: water up to 100%.
Method for controlling of bee varroatosis / 2294632
Claimed method includes introducing of filtering cardboard sheets on beehive bottom, wherein said sheets have size of 250x200x1 mm and contain 50-100 mg of fluvalinate for 25 days. Method of present invention makes it possible to increase treatment effectiveness and to exclude direct contact of treated surface with honeycomb.
 Intrahive varriatosis and nosematosis controlling method / 2296465
Method involves controlling varriatosis and nosema infections within hive by providing thermal treatment including heating of comb frames to temperature of 42-45 C directly within hive; locating bee stimulating source between outer honey frames, said source being made in the form of electrode grid; supplying current pulse functioning as bee stimulant to said electrode grid for enhancing motional activity of bees and increasing temperature within hive.
|
(57) Abstract: Use: beekeeping, healthy bee colonies from Nosema. The inventive composition includes fumagillin acid or salt of fumagillin acid and aliphatic amine, ascorbic acid, filler, sodium sanitarily and polyvinylpyrrolidone, in the respective proportions of the components, the filler contains glucose or lactose, or starch, or other sugars. 2 C.p. f-crystals, 1 table. The alleged invention relates to the field of agriculture, in particular animal, and can be used in beekeeping for the treatment of bee colonies, patients with Nosema. Known composition for combating bees Nosema, fumagillin-DCH-chinoin, including the active ingredient, ascorbic acid and filler (Guidance on the application of fumagillin-DCH to fight bees Nosema. Decl. The BS of the Ministry of agriculture of the USSR from 14.04.70). As the active substance contains salt fumagillin acid and dicyclohexylamine (DCG), as filler sodium phosphate, glucose. However, the known composition is not effective enough. The aim of the invention is the Ohm bees, including the active substance, ascorbic acid, and a filler, optionally containing sodium sanitarily and polyvinylpyrrolidone in the following ratio, wt. Active substance 1,0 5,0Ascorbic acid 0,2 1,5 Sodium sanitarily of 0.2 to 1.75 Polyvinylpyrrolidone 1,5 5,0 Filler Rest As the active substance use fumagillin acid or salt of fumagillin acid and aliphatic amine, as well as aliphatic amine can be used the following amines; dicyclohexylamine (DCG), decylamine (DCA), dodecylamine (DDA). Dicyclohexylamine is used as a corrosion inhibitor (Chemical dictionary, 1983). The decylamine used as a floating agent and the extractant in the extraction of non-ferrous and rare metals (Chemical dictionary, 1983). Dodecylamine is used in the manufacture of surface-active substances (surfactants) (Chemical dictionary, 1983). As filler can be used glucose, lactose, fructose, sucrose and starch. Polyvinylpyrrolidone (kollidon, luvisol) vysokomolecul is. 1977, S. 64). In the patent and scientific literature is not well-known technical task similarly claimed, i.e., the proposal meets the criterion of "Novelty." All the components used in the inventive mixture produced by the domestic industry, and therefore offer industrial feasible". In addition, the efficiency of the obvious composition follows from the properties of the components of the inventive mixture, therefore, the proposal meets the criterion of "Inventive step". Example 1. Mix 1.0 g of fumagillin acid, 0.2 g of ascorbic acid, 0.2 g of sodium semitecolo, 1.5 g of polyvinylpyrrolidone and 97.1 g of glucose, receiving structure 1 when the following ratio of components, wt. Fumagillin acid 1,0 Ascorbic acid 0,2 Sodium sanitarily 1,5 Filler Rest Example 2. Mixed with 2.8 g of fumagillin acid, 1.0 g of ascorbic acid, 1,25 g of sodium semitecolo, 3.75 g of polyvinylpyrrolidone and 91.2 g of glucose, receiving part 2 when the following ratio of components, wt. Fumagillin acid 2,8 Ascorbic acid 1,0 Sodium sanitarily 1,25 Polivinilovy acid, of 1.75 g of sodium semitecolo, 5.0 g of polyvinylpyrrolidone and 86,75 g glucose, receiving part 3 at the following ratio of components, wt. Fumagillin acid 5,0 Ascorbic acid 1,5 Sodium sanitarily 1,75 Polyvinylpyrrolidone 5,0 Filler Rest Example 4. Mix 1.0 g of salt fumagillin acid and dicyclohexylamine (DCG), 0.2 g of ascorbic acid, 0.2 g of sodium semitecolo, 1.5 g of polyvinylpyrrolidone and 97.1 g of glucose, receiving part 4 when the following ratio of components, wt. Salt fumagillin acid and aliphatic amine 1,0 Ascorbic acid 0,2 Sodium sanitarily 0,2 Polyvinylpyrrolidone 1,5 Filler Rest Example 5. Mixed with 2.8 g of salt fumagillin acid and DCG, 1.0 g of ascorbic acid, 1,25 g of sodium semitecolo, 3.75 g of polyvinylpyrrolidone and 91.2 g of glucose, receiving part 5 at the following ratio of components, wt. Salt fumagillin acid and aliphatic amine 2,8 Ascorbic acid 1,0 Sodium sanitarily 1,25 Polyvinylpyrrolidone 3,75 Filler Rest Example 6. Mix 5.0 g of salt fumagillin acid and DCG, 1.5 g asorrow the corresponding ratio of the components, wt. Salt fumagillin acid and aliphatic amine 5,0 Ascorbic acid 1,5 Sodium sanitarily 1,75 Polyvinylpyrrolidone 5,0 Filler Rest Example 7. Mix 1.0 g of salt fumagillin acid and decylamine (DCA), 0.2 g of ascorbic acid, 0.2 g of sodium semitecolo, 1.5 g of polyvinylpyrrolidone and 97.1 g of sucrose, receiving part 7 at the following ratio of components, wt. Salt fumagillin acid and aliphatic amine 1,0 Ascorbic acid 0,2 Sodium sanitarily 0,2 Polyvinylpyrrolidone 1,5 Filler Rest Example 8. Mixed with 2.8 g of salt fumagillin acid and DCA, 1.0 g of ascorbic acid, 1,25 g of sodium semitecolo, 3.75 g of polyvinylpyrrolidone and 91.2 g of sucrose, receiving part 8 when the following ratio of components, wt. Salt fumagillin acid and aliphatic amine 2,8 Ascorbic acid 1,0 Sodium sanitarily 1,25 Polyvinylpyrrolidone 3,75 Filler Rest Example 9. Mix 5.0 g of salt fumagillin acid and DCA, 1.5 g of ascorbic acid, 1.75 g of sodium semitecolo, 5.0 g of polyvinylpyrrolidone and 86,75 g sucrose, receiving part 9 PR is>/BR>Ascorbic acid 1,5 Sodium sanitarily 1,75 Polyvinylpyrrolidone 5,0 Filler Rest Example 10. Mix 1.0 g of salt fumagillin acid and dodecylamine (DDA), 0.2 g of ascorbic acid, 0.2 g of sodium semitecolo, 1.5 g of polyvinylpyrrolidone and 97.1 g of lactose, receiving structure 10 when the following ratio of components, wt. Salt fumagillin acid and aliphatic amine 1,0 Ascorbic acid 0,2 Sodium sanitarily 0,2 Polyvinylpyrrolidone 1,5 Filler Rest Example 11. Mix in 2.8 g of salt fumagillin acid and DDA, 1.0 g of ascorbic acid, 1,25 g of sodium semitecolo, 3.75 g of polyvinylpyrrolidone and 91.2 g of lactose, receiving part 11 when the following ratio of components, wt. Salt fumagillin acid and aliphatic amine 2,8 Ascorbic acid 1,0 Sodium sanitarily 1,25 Polyvinylpyrrolidone 3,75 Filler Rest Example 12. Mix 5.0 g of salt fumagillin acid and DDA, 1.5 g of ascorbic acid, 1.75 g of sodium semitecolo 5.0 g of polyvinylpyrrolidone and 86,75 g of lactose, the receiving part 12, with the following ratio of components, wt. Salt fumagillin vinylpyrrolidone 5,0 Filler Rest Example 13. Mix 1.0 g of salt fumagillin acid and DCG, 0.2 g of ascorbic acid, 0.2 g of sodium semitecolo, 1.5 g of polyvinylpyrrolidone and 97.1 g of fructose, receiving part 13 when the following ratio of components, wt. Salt fumagillin acid and aliphatic amine 1,0 Ascorbic acid 0,2 Sodium sanitarily 0,2 Polyvinylpyrrolidone 1,5 Filler Rest Example 14. Mixed with 2.8 g of salt fumagillin acid and DCG, 1.0 g of ascorbic acid, 1,25 g of sodium semitecolo, 3.75 g of polyvinylpyrrolidone and 91.2 fructose, receiving structure 14 when the following ratio of components, wt. Salt fumagillin acid and aliphatic amine 2,8 Ascorbic acid 1,0 Sodium sanitarily 1,25 Polyvinylpyrrolidone 3,75 Filler Rest Example 15. Mix 5.0 g of salt fumagillin acid and DCG, 1,5 ascorbic acid, 1.75 g of sodium semitecolo, 5.0 g of polyvinylpyrrolidone and 86,75 g fructose, receiving part 15 in the following ratio of components, wt. Salt fumagillin acid and aliphatic amine 5,0 Ascorbic acid 1,5 Sodium sanitarily 1,75 P and DCA, 0.2 g of ascorbic acid, 0.2 g of sodium semitecolo, 1.5 g of polyvinylpyrrolidone and 97.1 g of corn starch, receiving part 16 when the following ratio of components, wt. Salt fumagillin acid and aliphatic amine 1,0 Ascorbic acid 0,2 Sodium sanitarily 0,2 Polyvinylpyrrolidone 1,5 Filler Rest The composition can be tablet. Example 17. Mixed with 2.8 g of salt fumagillin acid and DCA, 1.0 g of ascorbic acid, 1,25 g of sodium semitecolo 3.75 g of polyvinylpyrrolidone and 91.2 g of corn starch, receiving part 17 when the following ratio of components, wt. Salt fumagillin acid and aliphatic amine 2,8 Ascorbic acid 1,0 Sodium sanitarily 1,25 Polyvinylpyrrolidone 3,75 Filler Rest The composition can be tablet. Example 18. Mix 5.0 g of salt fumagillin acid and DCA, 1.5 g of ascorbic acid, 1.85 g of sodium semitecolo, 5.0 g of polyvinylpyrrolidone and 86,75 g of corn starch, receiving structure 18 when the following ratio of components, wt. Salt fumagillin acid and aliphatic amine 5,0 Ascorbic acid 1,5 NAT is it. The specific activity of compounds 1 18 studied on bee families in the spring. To study the efficacy of the drug notesan on the subject of specific activity against the pathogen Nosema bees spent on bee families in the spring period (the period of maximum development of invasion). The degree of infestation of honey bee colonies Nosema apis spores was determined immediately after the exhibition colonies of bees from the apiary according to the "Methodological guidelines for the diagnosis of Nosema honey bees" appr. The BS of the Ministry of agriculture of the USSR 25.04.85, after which he formed the experimental and control group families of bees. This took into account the breed of bees, the age of Queen bees, effect of bee colonies in the streets, korvalainete, the number of open and capped brood, the degree of viral families Nosema. The test was used by 60 families of bees infected by Nosema, which were divided into 20 groups of 3 families in each. Before and after experiments from each group were sampled bees 30 50 individuals from each family for laboratory studies on Nosema. Bees received: 1. Sugar syrup (1:1) control. 2. Sugar syrup (1:1) + fumagillin-DCH. 3 20. Sugar syrup (1:1) + prepass from 14.04.70. Drug natesan (compounds 1 18) gave bee families from the calculation of 1.0 g per 1 liter of sugar syrup (1:1). Curative syrup nosecones gave the bees in the top feeders 250 300 ml within two weeks. About the effectiveness of medical treatments judged by the extense and intercoreennes bees disputes Nosema before and after the experiment. The data obtained during the experiments are presented in table 1. Data presented in table indicate the high efficiency of the use of the drug notesan in the spring by feeding with sugar syrup. The claimed composition (1 18) reduces exasperately bees with Nosema average of 20.0% and intemperately of 24.0% compared with a known composition (fumagillin-DCH-chinoin). 1. Composition for combating bees Nosema, including fumagillin acid or its salt with an aliphatic amine, ascorbic acid and a filler, characterized in that it contains sodium sanitarily and polyvinylpyrrolidone in the following ratio, wt. Fumagillin acid or its salt with an aliphatic amine 1,0 5,0 Ascorbic acid 0,2 1,5 Sodium sanitarily of 0.2 to 1.75 Polyvinylpyrrolidone 1,take dicyclohexylamine, or decylamine, or dodecylamine. 3. The composition according to PP. 1 and 2, characterized in that the filler contains glucose, or lactose, or fructose, or sucrose, or starch.
|
